Julie Dewey
Investor Relations Contact at ORTHOFIX MEDICAL INC.
Profile
Ms. Julie Dewey is a Chief Investor Relations & Communications Officer at Orthofix Medical, Inc. Ms. Dewey was previously employed as a Chief Communications & Investor Relations Officer by Treace Medical Concepts, Inc., a Chief Communications & Investor Relations Officer by Nevro Corp., a Chief Communications Officer & Senior VP by Wright Medical Group NV, and a Chief Communications Officer & Senior VP by Kyphon, Inc. She received her undergraduate degree from the University of Southern California and an MBA from Pepperdine University.
Julie Dewey active positions
Companies | Position | Start |
---|---|---|
ORTHOFIX MEDICAL INC. | Investor Relations Contact | 11/06/2024 |
Former positions of Julie Dewey
Companies | Position | End |
---|---|---|
NEVRO CORP. | Investor Relations Contact | 01/07/2023 |
WRIGHT MEDICAL GROUP N.V. | Public Communications Contact | 01/11/2020 |
Kyphon, Inc. | Public Communications Contact | 01/11/2007 |
TREACE MEDICAL CONCEPTS, INC. | Investor Relations Contact | - |
Training of Julie Dewey
University of Southern California | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
NEVRO CORP. | Health Technology |
TREACE MEDICAL CONCEPTS, INC. | Health Technology |
ORTHOFIX MEDICAL INC. | Health Technology |
Private companies | 2 |
---|---|
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Kyphon, Inc. |
- Stock Market
- Insiders
- Julie Dewey